Kiromic BioPharma, Inc. (KRBP) Securities Fraud Violations Class Action Lawsuit
The partial settlement of this federal securities fraud class action lawsuit is on behalf of investors who purchased or otherwise acquired Kiromic BioPharma, Inc. (“Kiromic”) (NASDAQ: KRBP) common stock (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the initial public offering (“IPO”) in or around June and July 2021; and/or (2) between June 25, 2021 and February 2, 2022, inclusive (the “Class Period”).
What’s the status of the Settlement?
On August 25, 2026 the Court granted Preliminary Approval of the partial Class Action Settlement with the Individual Defendants. There is a Final Settlement Hearing scheduled for December 17, 2026. The settlement website is active and open for claims.
The action against Defendant ThinkEquity LLC remains ongoing.
Who can file a claim?
The settlement class includes all persons or entities who:
- Purchased or otherwise acquired Kiromic common stock pursuant and/or traceable to the Offering Documents issued in connection with the IPO in or around June and July 2021; and/or
- Acquired Kiromic common stock between June 25, 2021 and February 2, 2022.
How much is the Settlement Payment?
Pro rata payment: The total settlement fund is $1,225,000. The amount each class member receives will depend on several factors, including:
- The number of valid claims submitted
- The number of shares purchased and sold
- The dates of purchase and sale
- The price paid for the shares and the price received upon sale
How do I file a claim?
The deadline to file a claim is December 14, 2026. To submit a claim and/or to find additional information regarding the terms of the partial settlement and claim filing process, go to www.strategicclaims.net/kiromic/, or contact the claims administrator, Strategic Claims Services, at 1-866-274-4004, or [email protected].
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected].
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.